Abu Dhabi launches new COVID-19 vaccine plant with China's Sinopharm
DUBAI (Reuters) -A new factory in Abu Dhabi will start manufacturing a COVID-19 vaccine from Chinese pharmaceutical giant Sinopharm later […]
FILE PHOTO: People sit at a cafe that reopened after the coronavirus disease (COVID-19) restrictions were eased, in Istanbul, Turkey […] GENEVA (Reuters) – The World Health Organization hopes to have doses of Johnson & Johnson’s COVID-19 vaccine for use in […] FILE PHOTO: Officials arrange boxes containing vials of COVISHIELD, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, […] BEIJING (Reuters) – China’s production capacity of COVID-19 vaccines could be sufficient for 40% of the population to have been […] HANOI/MOSCOW (Reuters) – Vietnam plans to acquire 150 million doses for its COVID-19 vaccination programme, as the health ministry said […] (Reuters) – CanSino Biologics Inc (CanSinoBIO) said on Wednesday it has filed an application in China for approval of its […] FILE PHOTO: People wearing face masks use their cellphones at a subway station following the coronavirus disease (COVID-19) outbreak, in […] (This Feb 11 story corrects to show CEO was referring to vaccine production not efficacy in headline, first and 4th […] (In Jan. 4 story, corrects paragraph 2 to say INO-4800 is being tested in three mid-stage trials, including one in […]Asia
Turkey logs 16,749 new COVID-19 cases, highest daily rise this year
WHO's Aylward hopes to have J&J vaccine in COVAX scheme by at least July
Big Indian state scales down vaccinations, citing shortage
China's COVID-19 vaccine production capacity may cover 40% of population by mid-2021: disease control head
Vietnam says panel recommends Sputnik V, Moderna vaccines for use
CanSinoBIO files application in China for COVID-19 vaccine approval
China reports 8 new COVID-19 cases vs 12 a day earlier
Vaccine production not perfect but our drug saves lives, AstraZeneca says, as Africa backs COVID-19 shot
Inovio expects to begin late-stage COVID-19 vaccine study in second quarter (Jan. 4)